Clinical Rheumatology

, Volume 35, Issue 3, pp 813–823 | Cite as

Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature

  • Yi Liu
  • Ding-Rong Zhong
  • Pei-Ran Zhou
  • Fang Lv
  • Dou-Dou Ma
  • Wei-Bo Xia
  • Yan Jiang
  • Ou Wang
  • Xiao-Ping Xing
  • Mei Li
Case Based Review


Gorham-Stout disease (GSD) is an exceedingly rare disease characterized by progressive osteolysis and angiomatosis. We investigate the features of this disease and evaluate the effects of bisphosphonates (BPs) on it. The clinical, radiological, and pathological characteristics of 12 patients diagnosed with GSD were summarized. Immunohistochemical staining with specific lymphatic endothelial markers (D2-40), vascular markers (CD 31, CD 34), and vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor 3 (VEGFR-3) was performed in specimens of bone biopsy. Patients were treated with either BPs or conjunction therapy of radiation and BPs. The effects of BPs were evaluated by the change of radiological progression, bone mineral density (BMD) and bone turnover biomarkers. To further evaluate the prognosis, a literature review was done. Idiopathic massive osteolysis was found in all patients, including 11 polyostotic and one mono-ostotic osteolysis. Soft tissue lymphangioma was presented in four patents. Four patients were complicated with chylothorax. Endothelial cells lining the proliferative vessels were positive for CD31 and CD34 and D2-40. Mild expression of VEGF and VEGFR-3 was also revealed. Stabilization in osteolysis and improvement in BMD were observed after single therapy with BPs or combined with radiotherapy. High mortality rate was found in patients with chylothorax. Spontaneous, progressive osteolysis is the most typical sign of GSD. BPs and radiotherapy can contribute to the clinical stabilization in bone lesion of GSD. The complicated chylothorax possibly indicates poor prognosis.


Bisphosphonate Gorham-Stout disease Osteolysis Radiotherapy 



We thank the support of the National Natural Science Foundation of China (81100623).




  1. 1.
    Jackson J (1838) A boneless arm. Boston Med Surg J 18:368–369CrossRefGoogle Scholar
  2. 2.
    Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37:985–1004PubMedGoogle Scholar
  3. 3.
    Motamedi MH, Homauni SM, Behnia H (2003) Massive osteolysis of the mandible: a case report. J Oral Maxillofac Surg 61:957–963CrossRefPubMedGoogle Scholar
  4. 4.
    Takahashi A, Ogawa C, Kanazawa T, Watanabe H, Suzuki M, Suzuki N, Tsuchida Y, Morikawa A, Kuwano H (2005) Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome. J Pediatr Surg 40:47–50CrossRefGoogle Scholar
  5. 5.
    Grunewald TG, Damke L, Maschan M, Petrova U, Surianinova O, Esipenko A, Konovalov D, Behrends U, Schiessl J, Wörtler K, Burdach S, von Luettichau I (2010) First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 21(8):1733–1734. doi: 10.1093/annonc/mdq331 CrossRefPubMedGoogle Scholar
  6. 6.
    Nir V, Guralnik L, Livnat G, Bar-Yoseph R, Hakim F, Ilivitzki A, Bentur L (2013) Propranolol as a treatment option in Gorham-Stout syndrome: a case report. Pediatr Pulmonol 49(4):417–419. doi: 10.1002/ppul.22869 CrossRefPubMedGoogle Scholar
  7. 7.
    Brodszki N, Lansberg JK, Dictor M, Gyllstedt E, Ewers SB, Larsson MK, Eklund EA (2011) A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr 100(11):1448–1453. doi: 10.1111/j.1651-2227.2011.02361.x CrossRefPubMedGoogle Scholar
  8. 8.
    Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024. doi: 10.1002/pbc.23124 CrossRefPubMedGoogle Scholar
  9. 9.
    Heffez L, Doku HC, Carter BL, Feeney JE (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55:331–343CrossRefPubMedGoogle Scholar
  10. 10.
    Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PC, Hughes D, Forsyth RG, Jackson D, Athanasou NA (2008) Lymphatics and bone. Hum Pathol 39:49–55CrossRefPubMedGoogle Scholar
  11. 11.
    Morley JE, Dawson M, Hodgkinson H, Kalk WJ (1977) Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 45:931–935CrossRefPubMedGoogle Scholar
  12. 12.
    Dellinger MT, Garg N, Olsen BR (2014) Viewpoints on vessels and vanishing bones in Gorham-Stout disease. Bone 63C:47–52. doi: 10.1016/j.bone.2014.02.011 CrossRefGoogle Scholar
  13. 13.
    Heyden G, Kindblom LG, Nielsen JM (1977) Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 59:57–61PubMedGoogle Scholar
  14. 14.
    Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G (2013) Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924. doi: 10.1007/s00256-012-1565-4 CrossRefPubMedGoogle Scholar
  15. 15.
    Tilling G, Skobowytsh B (1968) Disappearing bone disease, morbus Gorham. Report of a case. Acta Orthop Scand 39:398–406CrossRefPubMedGoogle Scholar
  16. 16.
    Moller G, Gruber H, Priemel M, Werner M, Kuhlmey AS, Delling G (1999) Gorham-Stout idiopathic osteolysis—a local osteoclastic hyperactivity? Pathologe 20:177–182CrossRefPubMedGoogle Scholar
  17. 17.
    Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81:1893–1897PubMedGoogle Scholar
  18. 18.
    Colucci S, Taraboletti G, Primo L, Viale A, Roca C, Valdembri D, Geuna M, Pagano M, Grano M, Pogrel AM, Harris AL, Athanasou NN, Mantovani A, Zallone A, Bussolino F (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21:207–218CrossRefPubMedGoogle Scholar
  19. 19.
    Dupond JL, Bermont L, Runge M, de Billy M (2010) Plasma VEGF determination in disseminated lymphangiomatosis-Gorham-Stout syndrome: a marker of activity? A case report with a 5-year follow-up. Bone 46:873–876. doi: 10.1016/j.bone.2009.11.015 CrossRefPubMedGoogle Scholar
  20. 20.
    Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460–476. doi: 10.1016/j.cell.2010.01.045 CrossRefPubMedGoogle Scholar
  21. 21.
    Kotecha R, Mascarenhas L, Jackson HA, Venkatramani R (2012) Radiological features of Gorham’s disease. Clin Radiol 67:782–788. doi: 10.1016/j.crad.2012.01.009 CrossRefPubMedGoogle Scholar
  22. 22.
    Cano B, Insa S, Cifrian C, Cortina H, Hernandez M (2006) Radiologic findings in Gorham-Stout syndrome. Radiologia 48:33–36CrossRefPubMedGoogle Scholar
  23. 23.
    Hammer F, Kenn W, Wesselmann U, Hofbauer LC, Delling G, Allolio B, Arlt W (2005) Gorham-Stout disease—stabilization during bisphosphonate treatment. J Bone Miner Res 20:350–353CrossRefPubMedGoogle Scholar
  24. 24.
    Noda M, Endo C, Hoshikawa Y, Ishibashi N, Suzuki T, Okada Y, Kondo T (2013) Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg 61:356–358. doi: 10.1007/s11748-012-0130-3 CrossRefPubMedGoogle Scholar
  25. 25.
    Stefanidou M, Ioannidou D, Panayotides J, Tosca A (2004) Cutaneous vascular malformation associated with osteolysis or Gorham’s sign. Int J Dermatol 43:958–961CrossRefPubMedGoogle Scholar
  26. 26.
    Tsang WM, Tong AC, Chow LT, Ng IO (2004) Massive osteolysis (Gorham disease) of the maxillofacial skeleton: report of 2 cases. J Oral Maxillofac Surg 62:225–230CrossRefPubMedGoogle Scholar
  27. 27.
    Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R (2005) Treatment of Gorham’s disease with zoledronic acid. Oral Oncol 41:747–750CrossRefPubMedGoogle Scholar
  28. 28.
    Escande C, Schouman T, Francoise G, Haroche J, Menard P, Piette JC, Bertrand JC, Ruhin-Poncet B (2008) Histological features and management of a mandibular Gorham disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e30–e37. doi: 10.1016/j.tripleo.2008.02.028 CrossRefPubMedGoogle Scholar
  29. 29.
    Lehmann G, Pfeil A, Bottcher J, Kaiser WA, Fuller J, Hein G, Wolf G (2009) Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg 129:967–972. doi: 10.1007/s00402-008-0742-3 CrossRefPubMedGoogle Scholar
  30. 30.
    Kuriyama DK, McElligott SC, Glaser DW, Thompson KS (2010) Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review. J Pediatr Hematol Oncol 32:579–584. doi: 10.1097/MPH.0b013e3181edb464 CrossRefPubMedGoogle Scholar
  31. 31.
    Pedroletti F, Rangarajan S, McCain JP, Velez I (2010) Conservative treatment of a pathologic fracture in a patient with Gorham-Stout disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:e49–e52. doi: 10.1016/j.tripleo.2009.08.045 CrossRefPubMedGoogle Scholar
  32. 32.
    Avelar RL, Martins VB, Antunes AA, de Oliveira Neto PJ, Andrade ES (2010) Use of zoledronic acid in the treatment of Gorham’s disease. Int J Pediatr Otorhinolaryngol 74:319–322. doi: 10.1016/j.ijporl.2009.12.007 CrossRefPubMedGoogle Scholar
  33. 33.
    Garbers E, Reuther F, Delling G (2011) Report of a rare case of Gorham-Stout disease of both shoulders: bisphosphonate treatment and shoulder replacement. Case Rep Rheumatol 2011:565142. doi: 10.1155/2011/565142 PubMedPubMedCentralGoogle Scholar
  34. 34.
    Heyd R, Rabeneck D, Dornenburg O, Tselis N, Zamboglou N (2011) Gorham-Stout syndrome of the pelvic girdle treated by radiation therapy: a case report. Strahlenther Onkol 187:140–143. doi: 10.1007/s00066-010-2174-6 CrossRefPubMedGoogle Scholar
  35. 35.
    Zheng MW, Yang M, Qiu JX, Nan XP, Huang LY, Zhang WD, Gong L, Huang ZZ (2012) Gorham-Stout syndrome presenting in a 5-year-old girl with a successful bisphosphonate therapeutic effect. Exp Ther Med 4:449–451PubMedPubMedCentralGoogle Scholar
  36. 36.
    Takamoto RM, Armstrong RG, Stanford W, Fontenelle LJ, Troxler G (1971) Chylothorax with multiple lymphangiomata of the bone. Chest 59:687–689CrossRefPubMedGoogle Scholar
  37. 37.
    Tie ML, Poland GA, Rosenow EC (1994) Chylothorax in Gorham’s syndrome. A common complication of a rare disease. Chest 105:208–213CrossRefPubMedGoogle Scholar
  38. 38.
    De Seze SHA (1956) Osteolyse essentiale scapulo-thoraco-brachiale. Rev Rhum Mal Osteoartic 23(6):517–523Google Scholar
  39. 39.
    Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40-B:494–501PubMedGoogle Scholar
  40. 40.
    Koblenzer PJ, Bukowski MJ (1961) Angiomatosis (hamartomatous hem-lymphangiomatosis). Report of a case with diffuse involvement. Pediatrics 28:65–76PubMedGoogle Scholar
  41. 41.
    Tucker SM (1967) Bilateral chylothorax with multiple osteolytic lesions? Generalized abnormality of lymphatic system. Proc R Soc Med 60:17–19PubMedPubMedCentralGoogle Scholar
  42. 42.
    Morphis LG, Arcinue EL, Krause JR (1970) Generalized lymphangioma in infancy with chylothorax. Pediatrics 46:566–575PubMedGoogle Scholar
  43. 43.
    Touraine RT, Balander AM (1970) Chylothorax et maladie de Gorham. Lyon Med 224:459–466PubMedGoogle Scholar
  44. 44.
    Kolpakova LV, Iaroshevskaia EN (1967) A case of massive regional osteolysis. Arkh Patol 29:75–77PubMedGoogle Scholar
  45. 45.
    Nozicka Z, Herout V, Fingerland A (1974) Gorham-Stout syndrome caused by hemangiolymphangioma. Cesk Patol 10:56–62PubMedGoogle Scholar
  46. 46.
    Choma ND, Biscotti CV, Bauer TW, Mehta AC, Licata AA (1987) Gorham’s syndrome: a case report and review of the literature. Am J Med 83:1151–1156CrossRefPubMedGoogle Scholar
  47. 47.
    Dickson GR, Mollan RA, Carr KE (1987) Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry 87:569–572CrossRefPubMedGoogle Scholar
  48. 48.
    Joseph J, Bartal E (1987) Disappearing bone disease: a case report and review of the literature. J Pediatr Orthop 7:584–588CrossRefPubMedGoogle Scholar
  49. 49.
    Marymont JV (1987) Comparative imaging. Massive osteolysis (Gorham’s syndrome, disappearing bone disease). Clin Nucl Med 12:153–154CrossRefPubMedGoogle Scholar
  50. 50.
    Lee S, Finn L, Sze RW, Perkins JA, Sie KC (2003) Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg 129:1340–1343CrossRefPubMedGoogle Scholar
  51. 51.
    Heyd R, Micke O, Surholt C, Berger B, Martini C, Fuller J, Schimpke T, Seegenschmiedt MH (2011) German Cooperative Group on Radiotherapy for Benign D. Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review. Int J Radiat Oncol Biol Phys 81:e179–e185CrossRefPubMedGoogle Scholar
  52. 52.
    Pfleger A, Schwinger W, Maier A, Tauss J, Popper HH, Zach MS (2006) Gorham-Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol 28(4):231–233CrossRefPubMedGoogle Scholar
  53. 53.
    Yildiz TS, Kus A, Solak M, Toker K (2009) The Gorham-Stout syndrome: one lung ventilation with a bronchial blocker. A case of Gorham’s disease with chylothorax. Pediatr Anaesth 19(2):190–191. doi: 10.1111/j.1460-9592.2008.02832.x CrossRefGoogle Scholar
  54. 54.
    Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, Gulhan B, Demiricin M, Kiper N (2009) Gorham-Stout syndrome with chylothorax: successful remission by interferon alph-2b. Pediatr Pulmonol 44(6):613–615. doi: 10.1002/ppul.20849 CrossRefPubMedGoogle Scholar
  55. 55.
    De Smet K, De MAesenner M, Huijssen-Huisman E, Van Gorp B (2010) A rare cause of dyspnea due to chylothorax. Emerg Radiol 17(6):503–505. doi: 10.1007/s10140-010-0898-3 CrossRefPubMedGoogle Scholar
  56. 56.
    Wijesinghe N, Lin Z, Swarbrick MJ, Jogia DM (2010) Cardiovascular images. Chylotamponade: an unusual manifestation of Gorham-Stout syndrome. Circ Cardiovasc Imaging 3(2):223–224. doi: 10.1161/CIRCIMAGING.109.877548 CrossRefPubMedGoogle Scholar
  57. 57.
    Bridszki N, Lansberg JK, Dictor M, Gyllstedt E, Ewers SB, Larsson MK, Eklund EA (2011) A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr 100(11):1448–1453. doi: 10.1111/j.1651-2227.2011.02361.x CrossRefGoogle Scholar
  58. 58.
    Hopmman SM, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RC, Merks JH (2012) PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A 158A(7):1719–23. doi: 10.1002/ajmg.a.35406

Copyright information

© International League of Associations for Rheumatology (ILAR) 2014

Authors and Affiliations

  • Yi Liu
    • 1
  • Ding-Rong Zhong
    • 2
  • Pei-Ran Zhou
    • 1
  • Fang Lv
    • 1
  • Dou-Dou Ma
    • 1
  • Wei-Bo Xia
    • 1
  • Yan Jiang
    • 1
  • Ou Wang
    • 1
  • Xiao-Ping Xing
    • 1
  • Mei Li
    • 1
  1. 1.Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of HealthPeking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical ScienceBeijingChina
  2. 2.Department of PathologyPeking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical ScienceBeijingChina

Personalised recommendations